Polio endgame risks and the possibility of restarting the use of oral poliovirus vaccine by Radboud J. Duintjer Tebbens, Kimberly M. Thompson

Get full text

Poliovirus vaccination during the endgame: insights from integrated modeling by Radboud J. Duintjer Tebbens, Kimberly M. Thompson

Get full text

Another look at silent circulation of poliovirus in small populations by Dominika A. Kalkowska, Radboud J. Duintjer Tebbens, Kimberly M. Thompson

Get full text

Costs and Benefits of Including Inactivated in Addition to Oral Poliovirus Vaccine in Outbreak Response After Cessation of Oral Poliovirus Vaccine Use by Radboud J. Duintjer Tebbens PhD, Kimberly M. Thompson ScD

Get full text

Combinations of Quality and Frequency of Immunization Activities to Stop and Prevent Poliovirus Transmission in the High-Risk Area of Northwest Nigeria. by Radboud J Duintjer Tebbens, Mark A Pallansch, Steven G F Wassilak, Stephen L Cochi, Kimberly M Thompson

Get full text

Costs of illness due to cholera, costs of immunization and cost-effectiveness of an oral cholera mass vaccination campaign in Zanzibar. by Christian Schaetti, Mitchell G Weiss, Said M Ali, Claire-Lise Chaignat, Ahmed M Khatib, Rita Reyburn, Radboud J Duintjer Tebbens, Raymond Hutubessy

Get full text